Para su Difusión
FTC Challenges Barrs Proposed Acquisition of Pliva
Fecha
The Federal Trade Commission today announced its decision to challenge Barr Pharmaceutical, Inc.’s proposed acquisition of Pliva d.d for approximately $2.5 billion. The FTC’s complaint alleges that...